These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32353358)

  • 21. Surgical aspects of removal of Essure microinsert.
    Albright CM; Frishman GN; Bhagavath B
    Contraception; 2013 Sep; 88(3):334-6. PubMed ID: 23290426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of laparoscopic removal of the Essure sterilization device for pelvic pain: a case series.
    Casey J; Aguirre F; Yunker A
    Contraception; 2016 Aug; 94(2):190-2. PubMed ID: 27063056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unilateral placement of the Adiana device after failed bilateral placement of the Essure device for hysteroscopic sterilization.
    Gimpelson RJ; Wagner CA
    J Minim Invasive Gynecol; 2010; 17(5):660-1. PubMed ID: 20728829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy after Essure placement: report of two cases.
    Moses AW; Burgis JT; Bacon JL; Risinger J
    Fertil Steril; 2008 Mar; 89(3):724.e9-11. PubMed ID: 17543963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of inorganic particles resulting from degradation of ESSURE® implants: Study of 10 cases.
    Catinon M; Roux E; Auroux A; Balter V; Fellah C; Trunfio-Sfarghiu AM; Sournies G; Vincent M
    Eur J Obstet Gynecol Reprod Biol; 2020 Jul; 250():162-170. PubMed ID: 32446147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subserosal misplacement of Essure device manifested by late-onset acute pelvic pain.
    Mahmoud MS; Fridman D; Merhi ZO
    Fertil Steril; 2009 Dec; 92(6):2038.e1-3. PubMed ID: 19819445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incorrect position of Essure microinserts 3 months after successful bilateral placement.
    Gerritse MB; Veersema S; Timmermans A; Brölmann HA
    Fertil Steril; 2009 Mar; 91(3):930.e1-5. PubMed ID: 18945426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two Surgical Techniques for Essure Device Ablation: The Hysteroscopic Way and the Laparoscopic Way by Salpingectomy with Tubal Interstitial Resection.
    Tissot M; Petry S; Lecointre L; Faller E; Baldauf JJ; Akladios C; Boisrame T
    J Minim Invasive Gynecol; 2019; 26(4):603. PubMed ID: 30064007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A kink is not always a perforation: assessing Essure hysteroscopic sterilization placement.
    Borley J; Shabajee N; Tan TL
    Fertil Steril; 2011 Jun; 95(7):2429.e15-7. PubMed ID: 21367412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essure hysteroscopic sterilization versus interval laparoscopic bilateral tubal ligation: a comparative effectiveness review.
    Ouzounelli M; Reaven NL
    J Minim Invasive Gynecol; 2015; 22(3):342-52. PubMed ID: 25499775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tubal perforation by Essure: three different clinical presentations.
    Langenveld J; Veersema S; Bongers MY; Koks CA
    Fertil Steril; 2008 Nov; 90(5):2011.e5-10. PubMed ID: 18692813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and histopathologic characteristics of patients undergoing surgical excision with Essure coils: Longitudinal experience at a women's specialty hospital.
    Banet N
    Ann Diagn Pathol; 2020 Jun; 46():151508. PubMed ID: 32199277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essure(®) for management of hydrosalpinx prior to in vitro fertilisation-a systematic review and pooled analysis.
    Arora P; Arora RS; Cahill D
    BJOG; 2014 Apr; 121(5):527-36. PubMed ID: 24393165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of Sterilization Techniques and Clinical Updates.
    Clark NV; Endicott SP; Jorgensen EM; Hur HC; Lockrow EG; Kern ME; Jones-Cox CE; Dunlow SG; Einarsson JI; Cohen SL
    J Minim Invasive Gynecol; 2018; 25(7):1157-1164. PubMed ID: 28939482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are Adverse Events Attributed to Essure Associated With Nickel Sensitization?
    Raison-Peyron N; Du-Thanh A; Compan C; Perrochia H; Francini S; Duflos C; Crochet P
    Dermatitis; 2020; 31(2):122-127. PubMed ID: 32168143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasound assessment of the Essure contraceptive devices: is three-dimensional ultrasound really needed?
    Paladini D; Di Spiezio Sardo A; Coppola C; Zizolfi B; Pastore G; Nappi C
    J Minim Invasive Gynecol; 2015 Jan; 22(1):115-21. PubMed ID: 25241073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of clinical data associated with Essure® sterilization devices: An expanded case series.
    Sánchez-Cuerda C; Cuadra M; Cabrera Y; Duch S; Fabra S; Peay-Pinacho J; Álvarez P; Rubio J; Álvarez Bernardi J; Lobo P
    Eur J Obstet Gynecol Reprod Biol; 2022 Nov; 278():125-130. PubMed ID: 36166976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essure Surgical Removal and Subsequent Resolution of Chronic Pelvic Pain: A Case Report and Review of the Literature.
    Lora Alcantara I; Rezai S; Kirby C; Chadee A; Henderson CE; Elmadjian M
    Case Rep Obstet Gynecol; 2016; 2016():6961202. PubMed ID: 26904330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-step transvaginal three-dimensional hysterosalpingo-foam sonography (3D-HyFoSy) confirmation test for Essure® follow-up: a multicenter study.
    Zizolfi B; Lazzeri L; Franchini M; Di Spiezio Sardo A; Nappi C; Piccione E; Exacoustos C
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):134-141. PubMed ID: 28067009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of tubal patency after essure placement.
    Rodriguez AM; Kilic GS; Vu TP; Kuo YF; Breitkopf D; Snyder RR
    J Minim Invasive Gynecol; 2013; 20(4):468-72. PubMed ID: 23541247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.